The January 2012 issue of the Journal of Commercial Biotechnology is now available. Contents include Original Articles, From the Boardroom, From the Classroom, Legal and Regulatory Update, and Book Reviews.
Individual papers are available for purchase. Subscription options are posted at http://commercialbiotechnology.com/about/subscriptions , and you may also request that your librarian subscribe at http://commercialbiotechnology.com/pages/view/library-subscription .
Table of Contents
Editorial
| Exciting changes | |
| Yali Friedman | |
Articles
| Bacterial proteins: A new class of cancer therapeutics | |
| Ananda Mohan Chakrabarty | |
| Industrial biotechnology – Markets and industry structure | |
| Gunter Festel, Christian Detzel, Ruth Maas | |
| Options to Change Medicare Payment for Outpatient Prescription Drugs and Biotechnology Products | |
| Thomas Barker, Maia Larsson | |
| The Emergence of Bio-Clusters in Egypt and South Africa | |
| Ramazan Uctu, Nirvana Shanalee Pillay | |
| Patent litigation in India and interim injunctions — An evolving jurisprudence | |
| Rajashree Sharma, Dinesh Kumar Sharma | |
From the Boardroom
| Digital health investment opportunities abound, but standouts deliver disruptive change | |
| G. Steven Burrill | |
| Strategies for Collaboration Agreements Focusing on Innovation | |
| Pamela Cox | |
| Biomarketing strategy and tactics 101 PART I of III | |
| Dimitris Dogramatzis | |
From the Classroom
| The University of Colorado Certificate Program in Bioinnovation and Entrepreneurship: An Interdisciplinary, Cross-Campus Model | |
| Madhavan Parthasarathy, David Forlani, Arlen Meyers | |
Legal and Regulatory Updates
| EU Legal & Regulatory Update | |
| Ewan Grist | |
| Post-Grant Review: The Good, the Bad and the Ugly for Biotechnology Companies | |
| Smitha Uthaman, Deborah Lu, Thomas Kowalski | |
Book Reviews
| Book Review: Constructing and Deconstructing Patents by Irah H. Donner | |
| David B. Orange | |
| Book Review: Plunkett’s Biotech & Genetics Industry Almanac 2012 | |
| Barry J. Marenberg |
For more information, see the Journal of Commercial Biotechnology at http://CommercialBiotechnology.com